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Background: The actin cytoskeleton-associated protein palladin plays an important role in cell motility, morphogenesis
and adhesion. In mice, Palladin deficient embryos are lethal before embryonic day (E) 15.5, and exhibit severe
cranial neural tube and body wall closure defects. However, the mechanism how palladin regulates the process of cranial
neural tube closure (NTC) remains unknown.
Methods: In this paper, we use gene knockout mouse to elucidate the function of palladin in the regulation of NTC process.
Results:We initially focuse on the expression pattern of palladin and found that in embryonic brain, palladin
is predominantly expressed in the neural folds at E9.5. We further check the major cellular events in the neural epithelium
that may contribute to NTC during the early embryogenesis. Palladin deficiency leads to a disturbance of cytoskeleton in
the neural tube and the cultured neural progenitors. Furthermore, increased cell proliferation, decreased cell
differentiation and diminished apical cell apoptosis of neural epithelium are found in palladin deficient embryos. Cell cycle
of neural progenitors in Palladin-/- embryos is much shorter than that in wt ones. Cell adhesion shows a reduction in
Palladin-/- neural tubes.
Conclusions: Palladin is expressed with proper spatio-temporal pattern in the neural folds. It plays a crucial role
in regulating mouse cranial NTC by modulating cytoskeleton, proliferation, differentiation, apoptosis, and adhesion of
neural epithelium. Our findings facilitate further study of the function of palladin and the underlying molecular
mechanism involved in NTC.
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Neurulation is the process that gives rise to the central
nervous system, whereby the neural plate undergoes
bending, elevating, fusion and remodeling to form the
neural tube [1, 2]. In the mouse, neurulation is divided
into two phases, primary and secondary neurulation.
The brain and most of the spinal cord are created during
primary neurulation, while the rest of the spinal cord is* Correspondence: zhugangw@shsmu.edu.cn
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lation, NTC is typically initiated at the midline of the
hindbrain/cervical boundary, which is termed closure 1.
Then neural tube fusion proceeds bi-directionally,
toward both the hindbrain and the spinal cord. NTC
also initiates at the midbrain/forebrain boundary and the
rostral end of the forebrain, these two initiation points
are designated closure 2 and closure 3, respectively.
Then closure 2 proceeds caudally and rostrally, closure 3
proceeds caudally. After closure 2 meets closure 1 at the
midbrain/hindbrain neuropore, and closure 3 meets
closure 2 at the anterior neuropore, the whole neural
tube closes completely [1, 3]. With the contribution of
genetic and environmental factors, neural tube may fail
to close, causing neural tube defects (NTDs) [4]. NTDsle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Tan et al. Neural Development  (2017) 12:4 Page 2 of 13are the second most common birth defects with an inci-
dence of 1:1000 in human births, after congenital heart
defects [3]. In terms of occurring at different axial levels,
there are three types of NTDs: exencephaly, spina bifida
and craniorachischisis, representing the cranial region
NTDs, spinal cord NTDs and NTDs along the entire
body axis, respectively [5].
Animal models ranging from flies to mice have
been used to explore the mechanisms underlying
NTC [6–10]. By 2009, the number of mouse mutants
and strains with NTDs exceeds 240, including 205
specific genes, 30 unidentified genes, and 9 multifac-
torial strains. These genes encode many diverse proteins
that participate in cellular functions and biochemical path-
ways [11]. With in toto live imaging of mouse morphogen-
esis technology, the NTC process can be observed
intuitively [12, 13]. Cellular events involved in NTC have
been clarified, including actin organization, proliferation,
differentiation, apoptosis, adhesion and so on [9, 10, 14].
However the molecular mechanisms behind the complex
process remain poorly understood.
Palladin was first found to be one of genes whose
expressions were up-regulated in acute promyelocytic
leukemia cell line NB4 with all-trans retinoic acid
(ATRA) treatment [15]. Shortly thereafter, it was
reported to colocalize with α-actinin in stress fibers [16].
To study the function of palladin in vivo, we previously
generated palladin gene knockout mice through hom-
ologous recombination, and observed NTD in palladin
deficient embryos which died before E15.5 [17]. We
demonstrated that peripheral nerves were not signifi-
cantly stunted and neurite outgrowth was not impaired
in Palladin-/- embryos [18]. However the reason that
deletion of palladin causes NTD was still unknown.
Over the past years, research on palladin has been
focused on its interacting proteins [19, 20], its role in
tumorigenesis and tumor invasion [21–24]. There are no
other but our previous reports on studying its role in
NTC. With the gene knockout mouse model, we have
the advantages to study the role that palladin plays
during NTC process. In this article, we describe that
palladin expresses predominantly in the neural folds at
E9.5 in wt mouse embryonic brain. NTD caused by palladin
deficiency exhibits normal neural tube closure 1 but defect-
ive closure 2 and closure 3. Deletion of palladin leads to
disrupted cytoskeleton, increased cell proliferation,
decreased differentiation apoptosis, and cell adhesion in the
developing neural folds. These results may partially explain
the causes of NTD in Palladin-/- embryos.
Methods
Mice
Mice containing a heterozygous deletion of palladin
were generated previously [17], and maintained on aninbred 129/Sv background under specific pathogen-free
(SPF) conditions.
Genotyping
Embryos at E9.5 were collected at somite stage 17–21,
embryos at E10.5 were collected at somite stage 32–36.
All experiments were performed using somite matched
wt and Palladin-/- embryos. Genotype analysis of
embryos and adult mice was performed as previously
described [17].
Immunofluorescence staining
Embryos were dissected and fixed in 4% paraformalde-
hyde overnight at 4 °C, dehydrated by sucrose series,
then frozen in a Tissue Tek O.C.T. compound (Sakura
Finetek, Torrance, CA), and processed to generate
10 μm frozen sections. For immunofluorescence stain-
ing, sections were treated with frozen absolute acetone
for 10 min, air dried, washed with PBS and blocked with
10% normal goat serum (Jackson ImmunoResearch
Laboratories) in 5% BSA/PBS for 15 min at room
temperature. After incubation overnight at 4 °C with
primary antibodies listed in Additional file 4: Table S1,
fluorescently labeled secondary antibodies (Invitrogen)
were then used and incubated for 1 h at room
temperature. After antibody staining, sections were
counterstained with DAPI and mounted with fluorescent
mounting medium (Dako). Imaging was performed on a
Nikon Eclipse 80i.
Neural progenitors preparation
E10.5 embryonic telencephalons were microscopically
dissected to separate the neuroepithelium from the
mesenchyme and non-neural ectoderm. The tissue was
triturated and trypsinized into single-cell suspension.
Single cells were then cultured in DMEM/F-12 medium,
a neural progenitor culture medium, containing 20 ng/ml
EGF (R&D systems) and 20 ng/ml bFGF (R&D systems) to
maintain the pluripotency. Neural progenitor cells
were identified by immunofluorescence with an anti-
body against Nestin.
Whole mount in situ hybridization (WISH)
WISH probes corresponding to the open reading frame
were performed as previously described [25]. WISH was
performed according to a standard procedure with
optimization [25]. Briefly, embryos were dissected and
fixed in 4% paraformaldehyde overnight at 4 °C, dehy-
drated and rehydrated through a graded methanol series.
Embryos were then permeabilized with 10 μg/ml protein-
ase K in PBS for 30 min at room temperature, hybridized
with 1 μg/ml digoxigenin (DIG)-UTP-labeled antisense or
sense riboprobes at 68 °C. After hybridization, embryos
were washed and incubated with blocking reagent for 1 h
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AP Conjugate (Roche) overnight at 4 °C. Signals were
detected using a DIG Nucleic Acid Detection Kit (Roche).
Images were taken using a Nikon SMZ 800. Primer
pairs for Palladin isoform 2 are: sense primer: CACACAC
TCGGCGCACACGC; antisense primer: CAACTGGGC
ACCAAATACGC.
TUNEL assay
Apoptotic cells on sections were detected using an In
Situ Cell Death Detection Kit (Roche) according to the
manufacturer’s protocol. Images were taken with a
Nikon fluorescent microscope.
Quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from E9.5 and E10.5 embryonic
brains using TriPure Isolation Reagent (Roche) according
to the manufacturer’s instructions. The RNA was immedi-
ately reverse transcribed into cDNA using PrimeScript
RT reagent kit (Takara) according to the manufac-
turer’s protocol. The process was performed under
the following conditions: 37 °C for 15 min, followed by 85 °
C for 5 s. SYBR Premix Ex Taq (Takara) was used for qRT-
PCR with gene specific primers that amplified across exon-
exon junctions. qRT-PCR was performed on an ABI Fast
7500 using the cycling conditions: 95 °C for 30 s, followed
by 40 cycles of 95 °C for 5 s, 60 °C for 30 s. The transcript
numbers were determined from the linear regression of the
standard curves. Each qRT-PCR was performed in triplicate
with normalization to Gapdh expression level.
Western blot analysis
Embryonic brains were dissected and treated with radio
immunoprecipitation assay (RIPA) lysis buffer (1% Nonidet
P-40, 0.1% SDS and 0.5% sodium deoxycholate in PBS) with
protease inhibitors mixture (Sigma). The protein
concentration was assayed by BCA protein assay kit
(Thermo). 50 μg of proteins were separated by SDS/
PAGE. The following antibodies and dilutions were
used: anti-Cyclin E polyclonal antibody (1:500, Santa
cruz), anti-α-actinin monoclonal antibody (1:800, Sigma-
aldrich), and anti-GAPDH monoclonal antibody (1:500,
Santa cruz). The membranes were incubated with
secondary antibodies (LI-COR), and then scanned with
the LI-COR Odyssey imaging system.
Cumulative BrdU Assay
Cumulative BrdU labeling in E10.5 embryos was
performed as previously described [26, 27]. Briefly, preg-
nant female mice were intraperitoneally injected with
BrdU (1 mg BrdU per 20 g body weight). A series of
repeated BrdU injection was performed at an interval of
two hours with the following time points: 30 min, 2 h
30 min, 4 h 30 min, 6 h 30 min, and 8 h 30 min.Embryos (n = 5 at each time point) were fixed 30 min
after the last injection, and processed to generate frozen
sections. Samples were then treated with 2 N HCl at
37 °C for 30 min, washed with PBS, incubated with
20 μg/ml proteinase K for 10 min at room temperature,
and treated with 0.1% Triton X-100 for 10 min at room
temperature for cell permeabilization. Treated sections
were incubated with an anti-BrdU antibody at 4 °C over-
night. Signals were detected using an Alexa Fluor 488
conjugated antibody. The proportion of BrdU positive
nuclei of neural progenitors was used to calculate Tc
(total cell-cycle length) and Ts (S phase) as previously
described [26].
Statistical analysis
The Student’s t test was used for statistical analyses.
Standard deviation was used to measure deviation from
the mean, for all experiments. For all of the statistical
tests, p values less than 0.05 were considered statistically
significant.
Results
Palladin deficient embryos exhibited severe cranial NTD
We have previously constructed palladin knockout
mice. Palladin-/- embryos showed severe cranial NTD
and died before E15.5 [17]. To further understand why
palladin disruption causes cranial NTD, we collected
embryos at E9.5 when Palladin-/- embryos can be distin-
guished from wt littermates by their failure to close the
cranial neural tube. We found that cranial neural tube
closure 1 initiated normally in Palladin-/- embryos, yet
closure 2 and closure 3 could not occur. Therefore they
displayed complete exencephaly from forebrain to
hindbrain (Fig. 1A).
The embryonic central nervous system (CNS) is pat-
terned along its left-right, dorsal-ventral, and antero-
posterior axes [28]. Neural patterning is the process that
provides regional identities in neural cells in accordance
with their location in the neural tube. In order to inves-
tigate whether palladin deficiency impairs the neural
patterning process, we used a brain mesenchyme
molecular marker Twist and a fore/midbrain molecular
marker Otx2 to examine the development of certain
parts of embryonic brain [29, 30]. The expression
pattern of these two molecules was not obviously altered in
Palladin-/- embryos at E9.5 (Additional file 1: Figure S1).
Palladin was located predominantly in the neural folds at
E9.5
We have previously determined that in E8.5 mouse
embryo, palladin was mainly expressed in neural plate,
while in E9.5 and E10.5 embryos, it showed ubiquitous
expression [17]. However, the specific cell types in
embryo where each isoform is expressed remain obscure.
Fig. 1 Palladin-/- embryos exhibit severe cranial neural tube defects at E9.5. A Whole mount embryos at E9.5 in dorsal and ventral view, anterior
to the top. Neural tube closure 1 (arrows in the upper panel) forms in both wt and Palladin-/- embryos. Neural tube closure 2 (top arrows in the
lower panel) and closure 3 (bottom arrows in the lower panel) fail to occur in Palladin-/- embryos. B Whole mount ISH of E9.5 wt embryos with
Palladin isoform 2 probe. Note the main expression of Palladin in the brain region (a). After whole mount ISH, embryos were transected (at the
indicated plane in a), Palladin locates predominantly in neural folds (b, c). The boxed region in b is shown at higher magnification in c.
Abbreviations: wt-wild type, ISH-in situ hybridization
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proteins in mice due to alternative splicing and different
promoter usage: isoform 1 encodes a 200 kDa protein,
isoform 2 encodes a 140 kDa protein, isoform 3 and 4
encode 90–95 kDa proteins, isoform 5 encodes a 50 kDa
protein [31]. Isoform 2 is the major isoform in mice
brain. To identify the specific palladin isoforms that
expressed in E9.5 mouse brains, we extracted total
mRNA from E9.5 wt brains and conducted qRT-PCRusing isoform-specific primers. Isoform 2 was detected
to express at much higher level than the other four
isoforms (Additional file 2: Figure S2). To further
characterize the expression pattern of isoform 2 during
cranial NTC at E9.5, WISH on E9.5 wt embryos were
performed. Embryos were then processed to generate
10 μm frozen sections. We found that the expression of
Palladin isoform 2 was restricted to the neural tube,
with no expression detected in mesenchyme or non-
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exencephaly phenotype observed in Palladin-/- embryos,
combined with the neural folds expression pattern of
palladin, it would be reasonable to hypothesize that
palladin might affect cranial NTC by regulating neural
folds behavior. In order to confirm this hypothesis, we
examined major cellular events that are essential for
neural epithelium during cranial NTC. Cellular events
have been inspected included cytoskeleton, proliferation,
differentiation, apoptosis and adhesion.
Cytoskeleton architecture was disturbed in palladin
deficient neural folds and cultured neural progenitors
Palladin is an actin cytoskeleton-associated protein. We
have previously reported that palladin deficiency resultedFig. 2 Cytoskeleton architecture is disturbed in Palladin-/- neural tube and
FITC-conjugated Phalloidin and an antibody against P-cofilin, cultured neur
conjugated Phalloidin. The bundles of stress fibers in Palladin-/- neural tube
Nestin positive cells is over 98% in both wt and Palladin-/- neural progenito
compared with wt (g) (B, C) mRNA levels of α-actinin (B) and Argbp2 (C) ar
-actinin is down-regulated in Palladin-/- embryo brains as assayed by western
g and h. Error bars indicate SEM; *P < 0.05, ***P < 0.001in weakened actin stress fibers in mouse embryonic
fibroblast (MEF) cells [17]. It is possible that cytoskel-
eton architecture in Palladin-/- neural folds might be
affected. To verify this speculation, transverse cryosec-
tions at the presumptive mid/hindbrain region from wt
and Palladin-/- embryos at E9.5 were stained with an
F-actin marker FITC-phalloidin to visualize actin stress
fibers. The actin stress fibers (phalloidin positive) in
Palladin-/- neural tube were obviously fainter than those
in somite matched wt counterpart (Fig. 2A, a and b). We
also stained these sections with an antibody against
cytoskeleton marker P-cofilin to confirm this observation.
Conformably, actin cytoskeleton architecture was more
obscure in Palladin-/- neural tube compared with wt neural
tube (Fig. 2A, c and d).cultured neural progenitors. (A) Cross-sections of embryos stained with
al progenitors stained with an antibody against Nestin and FITC-
(b, d) become obscure and faint compared with wt (a, c). Ratio of
rs (e, f). Stress fibers in Palladin-/- neural progenitors are atrophic (h)
e down-regulated in Palladin-/- embryo brains as assayed by qPCR. (D) α
blotting. Magnifying power is 10X In A, e and f, while it is 20X in A,
Tan et al. Neural Development  (2017) 12:4 Page 6 of 13To determine the phenotype of cytoskeleton in Palladin-/-
neural tube in vitro, neural progenitors taken from E10.5
embryonic neuroepithelium were prepared and subjected
to immunostaining with Nestin (a neural stem cell and
neural progenitor marker). Results showed that both wt
and Palladin-/- neural progenitors were more than 98%
Nestin positive (Fig. 2A, e and f), which confirmed they
were truly neural progenitors. Neural progenitors were then
stained with FITC-phalloidin. F-actin showed a significant
decrease in E10.5 Palladin-/- neuroepithelium-derived
neural progenitors, compared to that in wt neural progeni-
tors (Fig. 2A, g and h).
In order to understand the mechanism behind the
decreased cytoskeleton in Palladin-/- neural tube, total
RNAs were extracted from E9.5 wt and Palladin-/-
embryonic brains, and reverse transcribed into cDNAs.
The mRNA expression of cytoskeleton related proteins
which can interact with palladin were then detected in
these two genotypic cDNAs by qRT-PCR. Genes have
been detected included α-actinin, Argbp2, Eps8, VASP,
AKT1, Profilin, LASP1, Clp36, Spin90, Ezrin, ILKAP, LPP
and Src [20, 31–41]. The expression of both α-actinin
and Argbp2 showed a significant decrease in Palladin-/-
embryonic brain-derived cDNAs compared to that in wt
cDNAs (Fig. 2B-C). mRNA levels of Eps8, VASP, AKT1,
Profilin, LASP1, Clp36, Spin90, Ezrin, ILKAP, LPP and
Src showed no remarkable difference between wt and
Palladin-/- brain at E9.5 (Additional file 3: Figure S3A).
To confirm this finding, proteins from wt and Palladin-/-
embryonic brains were prepared to perform western blot
assay, α-actinin was remarkably down-regulated in
Palladin-/- embryonic brains (Fig. 2D). The decreased
expression of these two genes may contribute to the
disturbed cytoskeleton in Palladin-/- neural tube.
Loss of palladin resulted in increased proliferation and
abnormal differentiation in neural folds
Cytoskeleton-associated proteins play a role in cell pro-
liferation [42]. Previous studies noted that proper prolif-
eration of neural progenitor cells is critical to NTC [43].
The observation that Palladin-/- embryos displayed
NTD suggested that proliferation might be disrupted in
Palladin-/- embryos. Therefore, transverse cryosections
from wt and Palladin-/- embryos at E9.5 and E10.5 were
stained with antibodies against phosphorylated-histone
H3-Ser10 (PH3, a M phase marker, marking mitotic
cells) and Ki67 (a late G1-M phase marker, marking all
dividing cells). For PH3 staining, the number of
PH3-positive cells was greatly increased in the region of
neural tube at both E9.5 and E10.5 (Fig. 3A, a, b, e and
f). PH3-positive cells in the neural tubes were quanti-
tated for 3 sections of each embryo (five embryos from
each genotype were stained). The average cell number
was compared using unpaired two-tailed student’s t testbetween wt and Palladin-/- neural tube. It led to a
significant difference in both E9.5 and E10.5 embryos
(Fig. 3B). Results also showed that at E9.5, there were
more PH3-positive cells in dorsal than ventral neural
tube in wt embryos (Fig. 3A, a). However, in Palladin-/-
embryos, the distribution of PH3-positive cells was more
uniform between the dorsal and ventral aspect of the
cranial neural tube (Fig. 3A, b). At E10.5, when the
cranial NTC finished, proliferation was uniform along
the dorso-ventral axis in both wt and Palladin-/- embryos
(Fig. 3A, e and f). Moreover, at E9.5, PH3-positive cells spe-
cifically distributed at the first layer of neural epithe-
lium at the duct edge in wt neural tube, while they
could also been seen in the more internal area in
Palladin-/- neural tube (arrows in Fig. 3A, a and b).
The abnormal proliferation showed in Palladin-/- em-
bryos was confirmed by Ki67 staining. Proliferation
was enormously increased in Palladin-/- neural tube
at both E9.5 and E10.5 (Fig. 3A, c, d, g and h).
The development of the nervous system is a very compli-
cated process. It is not only spatially but also temporally
regulated, depending on the production of functionally
diverse neuronal cell types at their proper locations. Differ-
entiation and proliferation of neural epithelium are related
and interdependent. Considering the abnormally increased
proliferation in Palladin-/- embryos, we speculated that
differentiation might be disrupted. Therefore, we stained
embryos at E9.5 and E10.5 with antibody against TuJ1 (also
know as beta III Tubulin, a neuronal differentiation
marker). At E9.5, in the ventral side of wt neural tube,
neural progenitors began to exit the cell cycle, and grad-
ually differentiate into neurons and glial cells, while no
differentiation could be seen in Palladin-/- embryos at the
same domain (Fig. 3A, c and d). Instead, differenti-
ation was observed in the dorsal half of the neural tube in
Palladin-/- embryos, which was not obvious in wt embryos
(Fig. 3A, c and d). Interestingly, the area with decreased
differentiation in the ventral side of neural tube was
corresponding to the region of abnormally increased
proliferation in Palladin-/- neural tube. Moreover, at
E10.5, with more proliferation in Palladin-/- than wt
embryos, differentiation declined in Palladin-/- embryos
compared with wt counterparts (Fig. 3A, g and h). This
unique correlated pattern of proliferation and differenti-
ation is a confusing issue.
Decreased cell-cycle length in palladin deficient neural
progenitors
In order to further elucidate the defects of increased
proliferation and decreased differentiation, cryosections
from E10.5 wt and Palladin-/- embryos were stained with
antibodies against Sox9 (a neural progenitor marker)
and P27 (a differentiated neuron marker). The number
of Sox9 positive cells and P27 positive cells in the ventral
Fig. 3 Proliferation is increased while differentiation is reduced in Palladin-/- neural tube. (A) Cross-sections of embryos are detected for PH3, Ki67
and Tuj1. Proliferation is increased in Palladin-/- neural tube at both E9.5 (b, green in d) and E10.5 (f, green in h). At E9.5, differentiation mainly
occurs in the ventral side of wt neural tube (red in c) but dorsal side of Palladin-/- neural tube (red in d). Differentiation is decreased in the ventral
side of neural tube in Palladin-/- at E10.5 (red in g and h). (B) Quantification of PH3-positive cells in the neural tube region at both E9.5 and E10.5.
(C) E10.5 neural tubes are detected for Sox9 and P27. Neural progenitors (green) are increased and differentiated neurons (red) are reduced in
Palladin-/- neural tube. The boxed region in g and h are shown at higher magnification in i and j respectively. (D) Quantification of the ratio of
progenitors to differentiated neurons at E10.5. White dotted lines outline the neural tube, yellow brackets indicate ventral side of the neural tube,
while arrows indicate abnormal proliferation in the internal area of neural tube. Error bars indicate SEM; ***P < 0.001
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the neural progenitors and the differentiated neurons.
Results showed neural progenitors increased and differenti-
ated neurons decreased in Palladin-/- neural tube (Fig. 3C).
The ratio of proliferating neural progenitors to differenti-
ated neurons was more than 2-fold increased in Palladin-/-
embryos than that in wt controls (Fig. 3D). Also qPCR ana-
lysis of neural progenitor genes Sox9, Nestin and Pax6 and
differentiation genes MAP2, Olig2 and Neurogenin2 was
performed to address the phonotype of increased prolifer-
ation and decreased differentiation, it turned out that the
expression of Sox9 increased in Palladin-/- embryos
(Additional file 3: Figure S3B).
Change in cell proliferation is often related to a change in
cell cycle length. Embryonic cell cycle process is mediated
by cyclins, cyclin-dependent kinases (cdks) and cyclin-
related proteins [44]. In order to verify whether the increase
of neural progenitors in E10.5 Palladin-/- neural tube was
due to a shortened cell cycle length, we first examined the
expression of cyclin E (a key positive regulator of cell cycle
phase G1/S), by western blotting on embryonic brainproteins from E10.5. Cyclin E showed a significant increase
in Palladin-/- embryonic brain (Fig. 4A). Cdk2 (a cyclin E
binding partner) was up-regulated and wee1 (a negative
regulator of phase G1/S) was down-regulated in E10.5
Palladin-/- brain, determined by qRT-PCR of E10.5 em-
bryonic brain cDNA (Fig. 4B-C). Expression of Cyclin
A, Cyclin B and Cyclin D1 was also addressed by qRT-
PCR, it showed no significant change in Palladin-/-
brain (Additional file 3: Figure S3C). This data suggested a
shortened G1/S length in cell cycle of neural progenitors in
Palladin-/- embryos. To verify this speculation, a cumula-
tive BrdU incorporation study was performed. At all the
five time points, the proportion of BrdU positive cells was
significantly higher in Palladin-/- neural tube than that in
wt neural tube (Fig. 4D). In wt cranial neural tube, the total
cell cycle length minus S phase length was 7.95 h, whereas
in Palladin-/- siblings it was shortened to 6.83 h (Fig. 4E).
Decreased apoptosis in neural folds after palladin disruption
Apoptosis plays an important role in NTC, tips of dorsal
neural folds undergo apoptosis process so that the
Fig. 4 Cell cycle of Palladin-/- neural progenitors at E10.5 is shortened. A Expression of Cyclin E in Palladin-/- embryo brains is up-regulated at
E10.5, as detected by western blotting. Expression of Cdk2 (a cell cycle enhancer) is up-regulated (B) while expression of Wee1 (a cell cycle
suppressor) is down-regulated (C) in Palladin-/- embryo brain at E10.5, as assayed by qPCR. Error bars indicate SEM; *P < 0.05. D BrdU labeling of
neural progenitors (pink) after indicated time of incubation. The proportion of BrdU-stained progenitors is higher in Palladin-/- neural progenitors
at each time point (right panel) compared with wt (left panel). E Cell cycle of neural progenitors in wt and Palladin-/- at E10.5, Tc-Ts is 7.95 h in
wt and 6.83 h in Palladin-/- neural progenitors (n = 5 at each time point). Error bars indicate SEM
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[45]. To investigate whether NTD in Palladin-/- embryos
was related to a change in apoptosis in the neural fold
region, TUNEL assay was performed on E9.5 cryosec-
tions. It revealed that Palladin-/- neural folds had a lower
level of apoptotic cells compared with that in wt neural
folds (Fig. 5A). TUNEL positive cells were quantitated,
and there was a significant decrease in Palladin-/- neural
tube (Fig. 5B). To confirm this finding, IHC for the anti-
body of caspase 3 was performed. It turned out a reduc-
tion in Palladin-/- neural tubes (Fig. 5C).
To further explore the mechanism of decreased
apoptosis, we detected key regulators of cell apoptosis
by qRT-PCR on E9.5 embryonic brain cDNAs. Genes
have been detected included Bcl2, Bcl-xl, Bad and
Bax. Bcl2, a negative regulator of apoptosis, was sig-
nificantly increased in Palladin-/- embryos (Fig. 5D,
Additional file 3: Figure S3D).Reduced cell adhesion in Palladin-/- neural tubes
Cell adhesion is another important factor that regulates
NTC. During the NTC process, after the formation of
dorsolateral hinge point (DLHP), neural epithelium
migrate from the lateral aspects of the neural tube to-
wards the midline, neural folds then fuse at their dorsal
tips to generate a closed neural tube [45]. We have pre-
viously observed that MEFs lacking of palladin showed
decreased adhesion to fibronectin compared to wt MEFs
[17], so we speculated that cell adhesion in Palladin-/-
neural folds would be compromised. To assess whether
palladin deficiency impaired cell adhesion on the tips of
the neural folds, the expression of E-cadherin (a key
component of cell adhesion) was first examined by
immunofluorescence staining on E9.5 cryosections. A
strong expression of E-cadherin could be detected on
the tips of neural folds in both wt and Palladin-/- embryos,
showing no significant difference (Fig. 6A).
Fig. 5 Cell apoptosis is decreased in Palladin-/- neural tube. A TUNEL assay shows decreased apoptosis in Palladin-/- neural tube at E9.5. B
Quantification of TUNEL positive cells/section from the neural tube region. C E9.5 neural tubes are detected for Caspase 3 by IHC. Apoptosis is
decreased in Palladin-/- neural tube. The neural fold region in a and b are shown at higher magnification in c and d respectively. D mRNA level of
Bcl2 is up-regulated in Palladin-/- embryo brain. White dotted lines outline the neural tube. Error bars indicate SEM; *P < 0.05, ***P < 0.001
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decreased in Palladin-/- MEFs [46]. Given that integrins
are critical for cell adhesion and migration [47, 48], we
had reasons to presume that β1-integrin might reduce in
Palladin-/- neural tube. We checked the expression of
β1-integrin on embryos at E9.5 by immunofluorescence
staining, and it turned out to be a decreased β1-integrin
in Palladin-/- neural tube (Fig. 6B).
Discussion
Although the function of palladin on actin organization,
cancer development and invasion has been described, also
molecular associations of palladin have been identified one
by one, little is known about the role palladin plays during
NTC process. In this paper, we show how palladin regulates
NTC in vivo. We found that deletion of palladin causes
changes of multiple cellular events which are critical for
NTC in the developing neural folds. Actin stress fibers
within the neuroepithelium is fainter. Proliferation of neural
epithelium is increased. Differentiation of neural progeni-
tors is decreased and abnormal spatially. Apoptosis is
decreased. Our results suggest that palladin may regulate
NTC by modulating these cellular events in the developing
neural folds. Hence a general genetic pathway from palladin
to the control of NTC has been established. Moreover, we
find expression changes of critical molecules for eachcellular events, it is absolutely useful for the establishment
of direct biochemical pathway for palladin to control of
NTC.
Research on expression analysis of palladin has been
described [31], we also have investigated stage- and
tissue-specific expression of palladin in early embryos
[17], However, no reports indicate the specific cell types
palladin is expressed during NTC, which is an import-
ant question for the study of palladin in NTC. Therefore,
we perform qRT-PCR and WISH, and identify that the
expression of palladin is highly restricted to the neural
epithelium in the embryonic brain at E9.5. This indicates
the particular and crucial role of palladin during NTC
process. Therefore, our research focuses on the neural
folds from E9.5 to E10.5.
Palladin is a cytoskeleton-associated protein. Research
in vitro indicated that palladin plays a critical role in
actin organization, our results confirmed this finding
in vivo. Cytoskeleton is fundamental for many cellular
processes, including cell proliferation and differentiation.
Since loss of palladin weakens actin network in the
developing neural folds, combined the phenotype of
extensive outgrowth of neural epithelium in Palladin-/-
embryos, it is an expected finding that proliferation is
increased in palladin deficient embryos. Since prolifera-
tion is often related to cell cycle, shortened cell cycle
Fig 6 Cell adhesion shows a reduction in Palladin-/- neural tube but not in non-neural ectoderm. (A) Cross-sections of wt and Palladin-/- embryos
at E9.5 are stained with an antibody against E-cadherin to detect cell adhesion in the surface ectoderm. There is strong expression of E-cadherin
at the edge of neural folds in both wt and Palladin-/- embryos. (B) Wt and Palladin-/- embryos at E9.5 are stained with an antibody against β1-
integrin. Cell adhesion is reduced in Palladin-/- neural tubes (a, c, g) than that in wt ones (b, d, h). The boxed regions in a and b are shown at
higher magnification in c and d, respectively
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neural epithelium, thus the cell cycle length was quali-
fied in vivo by cumulative BrdU assay. It turns out a
shorter cell cycle length in palladin deficient neural
progenitors, which explains the phenomenon of increased
proliferation. A report has showed that down-regulation of
palladin enhances cell vitality and proliferation in vitro [49],
which confirms our finding. However the mechanism of
palladin involving in regulating proliferation and cell cycle
has not yet been studied, a better understanding of this field
is necessary.
The fates of neural progenitors in the ventral side
of neural folds in the early embryogenesis are prolif-
eration and differentiation. Since proliferation is
increased in Palladin-/- neural progenitors, it is pos-
sible that differentiation in the corresponding location
is decreased. To confirm this hypothesis, we quantifythe ratio of proliferating neural progenitors to differ-
entiated neurons. It turns out a significant increased
ratio in palladin deficient neural tube compared to
that of wt. It should be noted that in the dorsal side
of neural folds, differentiated neurons is increased in
palladin deficient neural tube. This is probably a
consequence of disturbed cytoskeleton within the
neural tube, by differentiated neurons moving from
the ventral side to the dorsal side. There is a report
suggests that palladin knockdown may facilitate cell
differentiation in vitro [49]. It is commonly accepted
that dramatic cytoskeletal changes can trigger skeletal
muscle differentiation. However, more research is
needed to address whether the function of palladin in
regulating differentiation is positive or negative.
In the dorsal side of neural folds, neural epithelium
undergoes apoptosis to allow the two ends of neural folds
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the whole neural tube in palladin deficient embryos. So we
examine apoptosis in the dorsal side of neural folds, it turns
out a significant decreased apoptosis in palladin deficient
neural folds. So far, little is known on the role palladin plays
in cell apoptosis. For this reason, more research is needed
to complete this field.
In our previous study, palladin plays an important role
in regulating cell adhesion either in vivo or in vitro by sta-
bilizing β1-integrin [17, 46]. In addition, other researches
confirm this finding [50, 51]. So we examined the expres-
sion of β1-integrin in neural tube, and found it decreased
slightly in palladin deficient neural tubes. Nevertheless,
cell adhesion on the tips of neural folds is found to be nor-
mal in palladin deficient mouse embryos. It is possible that
in surface ectoderm, the function of palladin in cell adhe-
sion is compensated by other proteins in vivo during
mouse NTC. Myotilin and myopalladin are members of
the palladin/myotilin/myopalladin family [34]. Therefore,
further study is needed to determine whether myotilin
and myopalladin can functionally compensate for the loss
of palladin in vivo during NTC.
NTC is an extremely complex process during embryo-
genesis. Other than proliferation, differentiation, apop-
tosis and adhesion, there are other events involved in
NTC process. Correct head mesenchyme behaviors,
correct cell division direction of non-neural ectoderm,
intrinsic forces in neural plate are important for NTC
[1, 52, 53]. Therefore, to better understand the mech-
anism of palladin regulating NTC, the function of
palladin in these events requires further exploration.
Conclusions
In conclusion, our results demonstrate that actin-associated
protein palladin plays a role in cell proliferation, differenti-
ation and apoptosis in the developing neural folds to regu-
late NTC process. Our work provides an evidence that
palladin is a cell-cycle regulator spatially and temporally
required for the neural epithelium proliferation. We believe
our findings are helpful for further study of the function of
palladin and a better understanding of the underlying
molecular mechanism involved in NTC process.
Additional files
Additional file 1: Figure S1. Neural patterning is normal in Palladin-/-
embryos. Whole mount and section ISH of wt and Palladin-/- embryos for
Twist and Otx2 at E9.5. (A) Twist is located in the head mesenchyme
region in both wt (a, c, e) and Palladin-/- embryos (b, d, f). (B) Otx2 is
located in the forebrain and midbrain region in both wt (a, c, e) and
Palladin-/- embryos (b, d, f). The boxed regions in c and d are shown at
higher magnification in e and f. (TIF 7155 kb)
Additional file 2: Figure S2. Palladin isoform 2 is the main isoform
expressed in E9.5 mouse brain. Detection of Palladin isoforms in E9.5 wt
mouse brain by qRT-PCR using isoform-specific primers. Palladin isoform 2 isthe main expressing isoform. Isoform 3 and 4 were detected in a much lower
expression level. Isoform 1 and 5 were barely detected. (TIF 284 kb)
Additional file 3: Figure S3. mRNA level changes in Palladin-/- brain.
mRNA levels of Eps8, VASP, AKT1, Profilin, LASP1, Clp36, Spin90, Ezrin, ILKAP,
LPP and Src showed no remarkable difference between wt and Palladin-/-
brain at E9.5 (A). mRNA levels of neural progenitor genes Sox9, Nestin and
Pax6 and differentiation genes MAP2, Olig2 and Neurogenin2, expression
of Sox9 increased in Palladin-/- embryos at E10.5 (B). Expression of Cyclin
A, Cyclin B and Cyclin D1 showed no significant change in Palladin-/- brain
at E10.5 as assayed by qPCR (C). mRNA expression of BCL-XL, Bax and
Bad in wt and Palladin-/- embryonic brains. They show no significant
differences between wt and Palladin-/-. Error bars indicate SEM; *P < 0.05.
(TIF 1172 kb)
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